Inventor

LOVE KEVIN

US16 patents

⚠️ This page may combine multiple inventors who share the name “LOVE KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EAGLE BIOLOGICS INC

11 patents

US9925263B2Mar 27, 2018

Liquid pharmaceutical formulations for injection comprising procaine and uses thereof

EAGLE BIOLOGICS INC3 citations83

US9913905B2Mar 13, 2018

Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof

EAGLE BIOLOGICS INC5 citations83

US9833513B2Dec 5, 2017

Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof

EAGLE BIOLOGICS INC4 citations83

US11471479B2Oct 18, 2022

Polysaccharide and nucleic acid formulations containing viscosity-lowering agents

EAGLE BIOLOGICS INC3 citations72

US10849977B2Dec 1, 2020

Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof

EAGLE BIOLOGICS INC1 citations72

US11986526B2May 21, 2024

Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)

EAGLE BIOLOGICS INC0 citations61

US11819550B2Nov 21, 2023

Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)

EAGLE BIOLOGICS INC0 citations61

US10821183B2Nov 3, 2020

Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)

EAGLE BIOLOGICS INC0 citations51

NOVARTIS AG

4 patents

US10906867B2Feb 2, 2021

Lipids and lipid compositions for the delivery of active agents

NOVARTIS AG39 citations97

US10426737B2Oct 1, 2019

Lipids and lipid compositions for the delivery of active agents

NOVARTIS AG5 citations83

US11013696B2May 25, 2021

Lipids and lipid compositions for the delivery of active agents

NOVARTIS AG2 citations72

US11420933B2Aug 23, 2022

Lipids and lipid compositions for the delivery of active agents

NOVARTIS AG0 citations59

BRITO LUIS

1 patent

US10059655B2Aug 28, 2018

Lipids and lipid compositions for the delivery of active agents

BRITO LUIS6 citations83

LOVE KEVIN

EAGLE BIOLOGICS INC

Liquid pharmaceutical formulations for injection comprising procaine and uses thereof

Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof

Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof

Polysaccharide and nucleic acid formulations containing viscosity-lowering agents

Liquid Protein Formulations Containing Thiamine

Liquid protein formulations containing thiamine pyrophosphate (TPP)

Liquid protein formulations containing cimetidine

Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof

Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)

Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)

Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)

NOVARTIS AG

Lipids and lipid compositions for the delivery of active agents

Lipids and lipid compositions for the delivery of active agents

Lipids and lipid compositions for the delivery of active agents

Lipids and lipid compositions for the delivery of active agents

BRITO LUIS

Lipids and lipid compositions for the delivery of active agents